MIT Engineers Create At-Home Tests for Cancer Detection Similar to COVID-19 Tests

MIT engineers have developed a sensor that could revolutionize cancer diagnosis. Similar to at-home COVID tests, the sensor can detect multiple cancerous proteins with a urine sample. The test is affordable and accessible, with a strip of paper being the testing material. The MIT team has successfully tested the sensor on mice and is working toward human trials. The sensor can not only detect cancer, but it can also determine the type of tumor and how it responds to treatment. The ultimate goal of this technology is to democratize diagnostics and create inexpensive, fast, and accurate tests at the point of care. With the potential to measure post-treatment tumor activity, this sensor can be a groundbreaking development in cancer treatment.